Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells

Coral García-Fernández, Alba López-Fernández, Salvador Borrós, Martí Lecina*, Joaquim Vives*

*Autor correspondiente de este trabajo

Producción científica: Artículo en revista indizadaRecensiónrevisión exhaustiva

20 Citas (Scopus)

Resumen

Production of sufficient numbers of multipotent Mesenchymal Stromal Cells is a great challenge that the industry must address to meet the increasing demand for clinical size product batches. This can be understood as an opportunity to exploit existing bioprocessing technologies already tested successfully in the production of vaccines and biologicals. Herein we analyse the transition from traditional manual cell expansion 2D methodologies to scalable and automated platforms with the capacity to yield billions of cells per batch in a robust, reproducible and cost-effective manner in compliance with current Good Manufacturing Practices. This review gives special relevance to the key features of multiple manufacturing platforms, particularly those using microcarriers to support cell expansion and single-use bioreactors.

Idioma originalInglés
Número de artículo107601
Número de páginas12
PublicaciónBiochemical Engineering Journal
Volumen159
DOI
EstadoPublicada - 15 jul 2020

Huella

Profundice en los temas de investigación de 'Strategies for large-scale expansion of clinical-grade human multipotent mesenchymal stromal cells'. En conjunto forman una huella única.

Citar esto